Skip to content
OpenCapital
Get started

BioMarin Pharmaceuticals BMRN Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Biogen logo
BiogenBIIB
——
Globus Medical logo
Globus MedicalGMED
——

Other financials

Income statement

See full
Revenue$766.2M+2.8%
Gross profit$571.2M-3.8%
Operating income$129.6M-42.1%
Net income$105.5M-43.2%
EPS (diluted)$0.54-43.2%

Balance sheet

See full
Cash & equivalents$3.1B+193%
Total debt$1.4B+138%
Total equity$6.2B+7.2%
Total assets$8.6B+20.2%

Cash flow

See full
Operating cash flow$220.7M+26.5%
CapEx$20.9M+24.8%
Free cash flow$199.7M+26.7%

Valuation

See full
Market cap$10.57B-19.4%
Enterprise value$8.93B-29.3%
P/E21.1×-22.7×
P/S3.3×-1.2×

Profitability

See full
Gross margin76.5%-2.9pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin23.7%+2.5pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.2×+0.1×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioMarin Pharmaceuticals's finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioMarin Pharmaceuticals's finite lived intangible assets - gross?
BioMarin Pharmaceuticals (BMRN) reported finite lived intangible assets - gross of $722.36M in Q1 2026.
How has BioMarin Pharmaceuticals's finite lived intangible assets - gross changed year-over-year?
BioMarin Pharmaceuticals's finite lived intangible assets - gross increased by 0.2% year-over-year, from $721.11M to $722.36M.
What is the long-term trend for BioMarin Pharmaceuticals's finite lived intangible assets - gross?
Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's finite lived intangible assets - gross has grown at a 2.4% compound annual growth rate (CAGR), from $644.09M to $723.97M.